Dexrazoxane Prophylaxis

Dexrazoxane Prophylaxis is a cardioprotective pharmacological intervention that selectively mitigates anthracycline-induced cardiotoxicity through topoisomerase IIβ inhibition and iron chelation without compromising antitumor efficacy.

4

Publications

634

Citations

25

Authors

11

Institutions

Publications per year

2017–2026

1

Authors

25

  1. VM
    Vanessa McFadden

    Medical College of Wisconsin, United States

    1 publications · 19 citations

    1

    h-index

  2. LS
    Louis S. Constine

    University of Rochester Medical Center, United States

    1 publications · 485 citations

    1

    h-index

  3. WB
    Wendy B. London

    Children's Hospital of Philadelphia, United States

    1 publications · 485 citations

    1

    h-index

  4. BP
    Brad Pfeffer

    North Shore University Hospital, United States

    1 publications · 18 citations

    1

    h-index

  5. CK
    Cameron K. Tebbi

    Roswell Park Comprehensive Cancer Center, United States

    1 publications · 485 citations

    1

    h-index

1–5 of 25

Venues

  1. Journal of Clinical Oncology

    1 publications · 485 citations

    1

    h-index

  2. Journal of Pediatric Hematology/Oncology

    1 publications · 19 citations

    1

    h-index

  3. British Journal of Cardiology

    1 publications · 18 citations

    1

    h-index

  4. PubMed

    Repository · 1 publications · 112 citations

    1

    h-index

1–4